Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

6 clinical studies listed.

Filters:

Sick Sinus Syndrome

Tundra lists 6 Sick Sinus Syndrome clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

RECRUITING

NCT07360067

Prospective Cohort Study of Bachmann Bundle Versus Right Atrial Appendage Pacing: Impact on Atrial Cardiomyopathy Evaluated by Echocardiographic Parameters and Clinical Outcome

The goal of this observational study is to evaluate the impact of different atrial pacing sites-Bachmann's bundle pacing versus right atrial appendage pacing-on the development and progression of atrial cardiomyopathy in patients diagnosed with sick sinus syndrome who are undergoing permanent pacemaker implantation.

Gender: All

Ages: 19 Years - Any

Updated: 2026-01-22

1 state

Sick Sinus Syndrome
ENROLLING BY INVITATION

NCT04926792

Taiwan Registry for Leadless Pacemaker

Taiwan Registry for Leadless Pacemaker is a nationwide registry for leadless pacemaker performance in Taiwan.

Gender: All

Updated: 2026-01-08

Sick Sinus Syndrome
Atrioventricular Block
RECRUITING

NCT07314008

Left Bundle Branch Versus Minimized Ventricular Pacing in Patients With Sick Sinus Syndrome and Prolonged AV Interval

The goal of this clinical trial is to compare two pacemaker strategies: Left Bundle Branch Area Pacing (LBBAP) and Minimized Ventricular Pacing (MVP) in patients requiring a permanent pacemaker for sick sinus syndrome and prolonged AV interval. It will also evaluate the safety and feasibility of the LBBAP method in these patients. The main questions it aims to answer is: \*Is LBBAP with physiological AV interval better than Minimized Ventricular Pacing? Researchers will compare the LBBAP group (aiming for conduction system capture with physiological AV intervals) to the MVP group (aiming to minimize ventricular pacing with prolonged AV intervals) to evaluate the optimal pacing strategy. Participants will: * Be randomly assigned to either the LBBAP group or the MVP group. * Undergo a pacemaker implantation procedure according to the specific criteria for their assigned group. * Visit the clinic for regular checkups to measure pacing function and ensure the device settings remain compliant with the study protocol.

Gender: All

Ages: 18 Years - Any

Updated: 2026-01-02

1 state

Sick Sinus Syndrome
Atrioventricular Nodal Dysfunction
NOT YET RECRUITING

NCT07279207

PACE-AF: Prospective Analysis of Cardiac Electrostimulation and Atrial Fibrillation

PACE-AF is a prospective, observational patient registry designed to evaluate the impact of pacemaker algorithms on atrial fibrillation (AF) incidence, progression, and clinical outcomes in patients implanted with dual-chamber pacemakers. The registry aims to include 400-500 patients with longitudinal follow-up. Primary outcomes are progression to permanent AF and all-cause mortality. Secondary outcomes include quality of life, hospitalization, and cardiovascular events.

Gender: All

Ages: 18 Years - Any

Updated: 2025-12-12

1 state

Atrial Fibrillation
Sick Sinus Syndrome
Atrioventricular Block
RECRUITING

NCT06652750

Evaluating the Safety and Effectiveness of 5G Cloud Follow-up for Cardiovascular Implantable Electronic Devices

Objective: This clinical study employs a prospective, paired, self-controlled, non-inferiority, multicenter research design to assess the safety and efficacy of utilizing 5G cloud follow-up for CIED in parameters monitoring and remote programming post-implantation. Participants will: undergo regular clinic follow-up visits in accordance with the guidelines undergo routine in-office follow-up and 5G cloud follow-up during each regular clinic visit

Gender: All

Ages: 18 Years - Any

Updated: 2024-11-21

2 states

Sick Sinus Syndrome
Atrioventricular Block, Second and Third Degree
Heart Failure
RECRUITING

NCT06288633

Cardioneuroablation for Bradyarrhythmia

This is a multicenter prospective randomized blind controlled trial with a sham procedure group of the efficacy and safety of cardioneuroablation as a method of treating symptomatic bradycardia without a permanent pacemaker implantation

Gender: All

Ages: 18 Years - 65 Years

Updated: 2024-03-05

Bradycardia
Syncope
Sick Sinus Syndrome